These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22334592)

  • 21. MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.
    Safe S
    Curr Pharmacol Rep; 2015 Apr; 1(2):73-78. PubMed ID: 26457240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penfluridol Represses Integrin Expression in Breast Cancer through Induction of Reactive Oxygen Species and Downregulation of Sp Transcription Factors.
    Hedrick E; Li X; Safe S
    Mol Cancer Ther; 2017 Jan; 16(1):205-216. PubMed ID: 27811009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of oncogenic microRNA-17-92/ZBTB4/specificity protein axis in breast cancer.
    Kim K; Chadalapaka G; Lee SO; Yamada D; Sastre-Garau X; Defossez PA; Park YY; Lee JS; Safe S
    Oncogene; 2012 Feb; 31(8):1034-44. PubMed ID: 21765466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. REACTIVE OXYGEN SPECIES AND COLORECTAL CANCER.
    Sreevalsan S; Safe S
    Curr Colorectal Cancer Rep; 2013 Dec; 9(4):350-357. PubMed ID: 25584043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.
    Mertens-Talcott SU; Chintharlapalli S; Li X; Safe S
    Cancer Res; 2007 Nov; 67(22):11001-11. PubMed ID: 18006846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
    Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
    Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.
    Pathi S; Jutooru I; Chadalapaka G; Nair V; Lee SO; Safe S
    PLoS One; 2012; 7(10):e48208. PubMed ID: 23110215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic microRNA-27a is a target for anticancer agent methyl 2-cyano-3,11-dioxo-18beta-olean-1,12-dien-30-oate in colon cancer cells.
    Chintharlapalli S; Papineni S; Abdelrahim M; Abudayyeh A; Jutooru I; Chadalapaka G; Wu F; Mertens-Talcott S; Vanderlaag K; Cho SD; Smith R; Safe S
    Int J Cancer; 2009 Oct; 125(8):1965-74. PubMed ID: 19582879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
    Papineni S; Chintharlapalli S; Abdelrahim M; Lee SO; Burghardt R; Abudayyeh A; Baker C; Herrera L; Safe S
    Carcinogenesis; 2009 Jul; 30(7):1193-201. PubMed ID: 19406933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac sulfide inhibits colon cancer cell growth and downregulates specificity protein transcription factors.
    Li X; Pathi SS; Safe S
    BMC Cancer; 2015 Dec; 15():974. PubMed ID: 26673922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural Products as Mechanism-based Anticancer Agents: Sp Transcription Factors as Targets.
    Safe S; Kasiappan R
    Phytother Res; 2016 Nov; 30(11):1723-1732. PubMed ID: 27384261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
    Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
    Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?
    Kassouf W; Brown GA; Black PC; Fisher MB; Inamoto T; Luongo T; Gallagher D; Bar-Eli M; McConkey DJ; Adam L; Dinney CP
    J Urol; 2008 Sep; 180(3):1146-53. PubMed ID: 18639280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation.
    Banerjee N; Talcott S; Safe S; Mertens-Talcott SU
    Breast Cancer Res Treat; 2012 Nov; 136(1):21-34. PubMed ID: 22941571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
    Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
    Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of quercetin and hyperoside has anticancer effects on renal cancer cells through inhibition of oncogenic microRNA-27a.
    Li W; Liu M; Xu YF; Feng Y; Che JP; Wang GC; Zheng JH
    Oncol Rep; 2014 Jan; 31(1):117-24. PubMed ID: 24173369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer.
    Kasiappan R; Jutooru I; Karki K; Hedrick E; Safe S
    J Biol Chem; 2016 Dec; 291(53):27122-27133. PubMed ID: 27875298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer.
    Safe S; Shrestha R; Mohankumar K; Howard M; Hedrick E; Abdelrahim M
    World J Gastroenterol; 2021 Oct; 27(38):6387-6398. PubMed ID: 34720529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol and quercetin in combination have anticancer activity in colon cancer cells and repress oncogenic microRNA-27a.
    Del Follo-Martinez A; Banerjee N; Li X; Safe S; Mertens-Talcott S
    Nutr Cancer; 2013; 65(3):494-504. PubMed ID: 23530649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.